We yu dɔktɔ tɛl yu se yu gɛt Tayp 2 Dayabitis, dɛn kin gi yu mɛrɛsin lɛk Canagliflozin (Invokana) fɔ ɛp fɔ kɔntrol yu blɔd shuga, wit chenj dɛn na yu layf lɛk aw yu de it ɛn ɛksesaiz. Yu kin gɛt bɔku kwɛstyɔn bɔt dis mɛrɛsin. So lɛ wi tɔk bɔt am tide.
Wetin na Kanagliflɔzin (Invokana)?
Dis na yɔlɔ, we tan lɛk kapsul. Yu fɔ tek am wan tɛm insay di de, bifo yu it di fɔs it insay di de. Di men tin fɔ dis mɛrɛsin na fɔ mek yu nɔ gɛt di sik we de na di kidni we de dɔn, we kin kam wit dayabitis, ɛn fɔ ridyus di risk fɔ gɛt big big tin dɛn we kin apin to yu at lɛk at atak ɛn strok.
Bɔt wan tin we wi fɔ mɛmba na dat, pɔsin we gɛt Tayp 1 Dayabitis nɔ go ebul fɔ yuz dis mɛrɛsin.
Aw Kanagliflozin de wok na wi bɔdi?
Fɔ tɔk am simpul wan, dis mɛrɛsin de ɛp wi kidni fɔ pul di shuga (glukɔs) we pasmak na di bɔdi tru di urine.
fכ εksplen dis sכmtεm, dis mεdisin de pan wan grup כf dεm we dεn kכl sכdiכm-glukoz transpכt protin 2 (SGLT2) inhibito dεm. Dis mɛrɛsin kin mek di shuga we de na di blɔd nɔ go bak insay di bɔdi we wi kidni dɛn filta am. Dɔn, di shuga we pasmak kin kɔmɔt na di bɔdi izi wan insay di urine. Dis kin mek yu blɔd shuga go dɔŋ.
We yu gɛt tayp 2 dayabitis, yu kidni dɛn fɔ wok tranga wan fɔ filta dis ɛkstra shuga. Dis ekstra prɛshɔn kin pwɛl yu kidni dɛn as tɛm de go. Kanagliflozin de ɛp fɔ ridyus dis prɛshɔn ɛn kɔntrol di kidni dɛm we de pwɛl.
Yu tink se dis mɛrɛsin kin rili ɛp yu fɔ lɛf fɔ it bɔku bɔku it dɛn?
Dɛn nɔ mek dis mɛrɛsin fɔ ɛp yu fɔ lɛf fɔ it bɔku bɔku it dɛn. Bɔt stɔdi dɔn sho se Canagliflozin kin ɛp yu fɔ lɔs sɔm pawn. Yu kin si dis we aw yu de lɔs yu wet ilɛksɛf yu tek am yu wan ɔ wit ɔda mɛrɛsin fɔ dayabitis, lɛk mɛtfɔmin.
Bɔt di kayn we aw pɔsin kin lɔs in wet kin difrɛn frɔm wan pɔsin to ɔda pɔsin . Di doz fɔ di mɛrɛsin we yu de tek kin afɛkt dis bak. Tipikli, yu kin lɔs bitwin 2% ɛn 3% pan yu bɔdi wet. Bɔt bifo yu bigin ɛni nyu it ɔ ɛksesaiz program we yu de tek dis mɛrɛsin, yu fɔ rili tɔk to yu dɔktɔ .
Wetin na di sayd ɛfɛkt ɛn risk dɛm fɔ Canagliflozin?
Lɛk ɛni mɛrɛsin, Canagliflozin kin mek sɔm pipul dɛn gɛt smɔl, smɔl, ɔ siriɔs sayd ɛfɛkt.
Hypoglycemia (we di blɔd shuga nɔ bɔku) .
Dis mɛrɛsin kin mek sɔm pipul dɛn nɔ gɛt bɛtɛ blɔd shuga (hypoglycemia) we denja. Dis risk kin pasmak if yu tek ɔda mɛrɛsin fɔ gɛt dayabitis, lɛk insulin, glipizide, ɔ glyburide, wit dis mɛrɛsin.
| Simptom dɛm fɔ Hypoglycemia | |
|---|---|
| Di bɔdi we de shek shek | Bɔdi At rit de go ɔp |
| We pɔsin de swet | Fɔ fil se yu nɔ de rɛst ɔ yu nɔ de rɛst |
| Diziz we pɔsin kin gɛt | Angri pasmak |
| Bɔdi ɛn maynd kɔnfyushɔn | Lɔs pan kɔnshɛns pan siriɔs kes dɛm |
If yu gɛt ɛni wan pan dɛn sik ya we yu de tek Canagliflozin, we min se yu fil lɛk se yu blɔd shuga nɔ bɔku, tɛl yu dɔktɔ wantɛm wantɛm .
Risk fɔ mek dɛn kɔt dɛn an
Dis kin tan lɛk se i de mek pɔsin fred, bɔt i nɔ kin apin so ɔltɛm . Sɔm stɔdi dɔn sho se Canagliflozin kin mek yu gɛt fɔ pul yu fut ɔ pat pan yu fut smɔl. Bɔt dɔktɔ dɛn biliv se di bɛnifit dɛn we pɔsin kin gɛt we i tek dis mɛrɛsin, pas di prɔblɛm dɛn we i kin gɛt fa fawe.
Yu dɔktɔ na di bɛst pɔsin fɔ disayd if dis mɛrɛsin fayn fɔ yu, so tɔk to am bɔt am.
Bɔku tin dɛn de we kin mek dɛn kɔt in leg bɔku:
- If dɛn dɔn pul pat pan di leg bifo tɛm
- If yu gɛt sik we de mek yu at ɛn blɔd
- If di nerv dεm dεn dεm dεm (neuropathy) .
- If yu gɛt dayabitik fut ɔlsa bikɔs ɔf dayabitis
- If yu dɔn pas 65 ia
Fɔ avɔyd dis risk, na fɔ no ɔltɛm bɔt ɛni wund, sɔri, pen, ɔ sayn fɔ infekshɔn na yu leg.If yu si ɛnitin lɛk dat, tɛl yu dɔktɔ wantɛm wantɛm.
Ɔda prɔblɛm dɛn we kin apin
- Bεlε εn bεlε: Dis mεrεsin kin bεn yu pikin if yu bεlε, spεshal wan insay di sεkכn כ tכd trimεst. dεn nכ no bak if i de pas insay mama in milk. So if yu de plan fɔ gɛt bɛlɛ, yu gɛt bɛlɛ, ɔ yu de gi pikin in bɛlɛ, mek shɔ se yu tɛl yu dɔktɔ bifo yu tek dis mɛrɛsin.
- Kidni ɛn liva sik: Dis mɛrɛsin nɔr fayn fɔ pipul dɛm wae gɛt siriɔs kidni ɔr liva sik, bikɔs i kin mek yu sik wɔs.
Yu kin tek Kanagliflozin togɛda wit Metformin?
Yɛs, yu kin ebul. Di men tin we di mɛrɛsin we dɛn kɔl Metformin de du na fɔ ridyus di shuga we de kɔmɔt na yu intestinal, fɔ ridyus di shuga we dɛn dɔn kip na di liva, ɛn ɛp di bɔdi fɔ yuz shuga.
Sɔntɛnde, yu dɔktɔ kin gi yu wan kɔmbayn pil we de jɔyn dɛn tu mɛrɛsin ya. Di brand nem fɔ di drɔg na Invokamet. Tu kayn dis mɛrɛsin de. Dɛn kin tek wan (Invokamet XR) wan tɛm insay di de ɛn dɛn mek am fɔ absɔb am sloslo. Dɛn kin tek di ɔda wan (Invokamet) tu tɛm insay di de ɛn i kin absɔb kwik kwik wan. Yu dɔktɔ go disayd uswan go fayn fɔ yu.
Aw bɔku dis mɛrɛsin de kɔst?
Canagliflozin na jɔs wan mɛrɛsin we dia pasmak. If yu de gɛt tritmɛnt na pɔblik ɔspitul, yu kin ebul fɔ gɛt dis mɛrɛsin fɔ fri. If yu de gɛt tritmɛnt prayvet wan, di prayz kin difrɛn difrɛn wan bay usay yu gɛt di mɛrɛsin ɛn if yu gɛt wɛlbɔdi inshɔrans. Yu dɔktɔ na di bɛst pɔsin fɔ tɔk to bɔt dis. So aks dɛn bɔt di kɔst ɛn di tin dɛn we yu go ebul fɔ du.
Mɛsej we dɛn kin kɛr go na os
- Canagliflozin (Invokana) na wan mɛrɛsin wae dɛn kin yuse fɔ trit tayp 2 dayabitis. I de wok bay we i de pul di shuga we pasmak na di bɔdi tru di urine.
- Dis mɛrɛsin fɔ tek wan tɛm insay di de, bifo di fɔs it fɔ di de. Tray fɔ tek am di sem tɛm ɛvride.
- Sɔm bad tin dɛn lɛk we yu blɔd shuga nɔ bɔku (haypoglycemia) ɛn yurinary tract infection kin apin. If yu gɛt ɛni sayn we nɔ kɔmɔn, tɛl yu dɔktɔ wantɛm wantɛm.
- Yu fɔ no ɔltɛm fɔ ɛni injuri, pen, ɔ swɛla na yu leg. Ripɔt ɛni smɔl smɔl sayn to yu dɔktɔ.
- Mek shɔ se yu tɛl yu dɔktɔ bɔt ɛni ɔda mɛrɛsin we yu de tek, ɛn if yu gɛt bɛlɛ ɔ yu plan fɔ gɛt bɛlɛ.
💬 Comments (0)
No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.
Ad yu kɔmɛnt